Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction

NCT03169582 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2017-05-30

No results posted yet for this study

Summary

The main goal of this study is to compare the use of Avanafil versus Sildenafil in spinal cord injury erectile dysfunction. The study has the characteristics of a non- inferiority, randomized, crossover, open clinical trial. The principal variable is the IIEF-EF (Erectile Function Domain questionnaire of the International Index of Erectile Function IIEF).

This is an interventional study

Conditions

Interventions

DRUG

Avanafil

Drug administration (Avanafil)

DRUG

Sildenafil

Drug administration (Sildenafil)

Sponsors & Collaborators

  • Eduardo Vargas-Baquero

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03169582 on ClinicalTrials.gov